Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review-Reference-Cited by-同舟云学术

Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review

Published:2021-11-01 Issue:11 Volume:8 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Whelchel Kristen¹^ORCID,Zuckerman Autumn D¹^ORCID,Koren David E²^ORCID,Derrick Caroline³,Bouchard Jeannette⁴^ORCID,Chastain Cody A⁵^ORCID

Affiliation:

1. Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA

2. Department of Pharmacy Services, Temple University Health System, Philadelphia, Pennsylvania, USA

3. Department of Infectious Disease, University of South Carolina, Columbia, South Carolina, USA

4. Department of Pharmacy, University of South Carolina, Columbia, South Carolina, USA

5. Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Abstract

Abstract Limited data exist regarding the use of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) in patients who are unable to swallow tablets. This case series describes HCV treatment in patients requiring tablet manipulation, providing evidence for safety and effectiveness of HCV DAA tablet manipulation.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/article-pdf/8/11/ofab525/41174697/ofab525.pdf

Reference25 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.;Polaris Observatory HCV Collaborators.;Lancet Gastroenterol Hepatol,2017

2. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016.;Hofmeister;Hepatology,2019

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.;van der Meer;JAMA,2012

4. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.;Morgan;Ann Intern Med,2013

5. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.;Sise;Hepatology,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource‐limited settings;Journal of Pediatric Gastroenterology and Nutrition;2024-02-18

2. Pellet-based hepatitis C virus treatment with glecaprevir/pibrentasvir: A case report of an adult with short bowel syndrome;Journal of Hepatology;2023-11

3. Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus;Infectious Disease Clinics of North America;2023-09

4. Treatment-experienced patient with Roux-en-Y gastric bypass successfully treated with sofosbuvir/velpatasvir/voxilaprevir: A case report;American Journal of Health-System Pharmacy;2022-12-08

5. A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-11-25